University of Missouri-Columbia
OrganisationROR
People
Associate professor14 Sept 2026reporter.nih.gov
Director of tlro14 Sept 2026reporter.nih.gov
Professor14 Sept 2026reporter.nih.gov
Research assistant professor11 Sept 2026reporter.nih.gov
Professor4 Sept 2026reporter.nih.gov
19 Aug 2026reporter.nih.gov
Professor, school of medicine3 Aug 2026reporter.nih.gov
Professor of child health3 Aug 2026reporter.nih.gov
Associate professor29 Jul 2026reporter.nih.gov
14 Jul 2026reporter.nih.gov
Associate professor8 Jun 2026reporter.nih.gov
Associate professor25 May 2026reporter.nih.gov
Assistant research professor25 May 2026reporter.nih.gov
Professor25 May 2026reporter.nih.gov
Associate professor12 May 2026reporter.nih.gov
Associate professor7 Apr 2026reporter.nih.gov
Professor23 Mar 2026reporter.nih.gov
Professor23 Mar 2026reporter.nih.gov
Research investigator / professor med23 Mar 2026reporter.nih.gov
Camila Margarita Manrique Acevedo
Associate professor of medicine23 Mar 2026reporter.nih.gov
Trials
Effects of Sirolimus on Asymptomatic ApoE4 Carriers
Phase 1Recruiting2026225 people27 Jul 2026clinicaltrials.gov
CollaboratorPhase 2Recruiting202550 people20 Dec 2024clinicaltrials.gov
Early phase 1Recruiting202464 people25 Jul 2024clinicaltrials.gov
Phase 2/3Recruiting202480 people17 Jul 2024clinicaltrials.gov
Phase 1Withdrawn20210 people18 Jun 2023clinicaltrials.gov
Phase 1Active, not recruiting2023205 people23 May 2022clinicaltrials.gov
Early phase 1Completed202028 people17 Feb 2022clinicaltrials.gov
Phase 2Recruiting202028 people24 Jun 2020clinicaltrials.gov
Phase 4Recruiting2019200 people2 Dec 2019clinicaltrials.gov
Phase 4Terminated201995 people28 Jun 2019clinicaltrials.gov
Phase 4Recruiting201930 people29 Aug 2018clinicaltrials.gov
CollaboratorPhase 4Enrolling by invitation20182,868 people9 Aug 2017clinicaltrials.gov
Early phase 1Completed201610 people23 Jun 2016clinicaltrials.gov
Early phase 1Withdrawn20150 people14 May 2015clinicaltrials.gov
Phase 4Withdrawn20140 people13 Oct 2014clinicaltrials.gov
CollaboratorPhase 2Completed201889 people21 Apr 2014clinicaltrials.gov
Phase 4Terminated2014142 people29 Jan 2014clinicaltrials.gov
Early phase 1Withdrawn20090 people27 Jan 2009clinicaltrials.gov
Phase 3Completed199524 people11 Dec 2007clinicaltrials.gov
Phase 4Terminated200711 people18 Apr 2007clinicaltrials.gov
Grants and prizes
K02Mediators of Muscle Rejuvenation with AgingK02AG088465US$142.8k2025–203014 Sept 2026reporter.nih.gov
National Institute of Arthritis and Musculoskeletal and Skin Diseases
R01Biomarkers for Predicting Osteoarthritis Incidence in At-Risk IndividualsR01AR087141US$456.8k2026–203014 Sept 2026reporter.nih.gov
K99Bioenergetic Reprogramming through Ketogenic Enzymes: A Mitochondrial Strategy for Alzheimer's DiseaseK99AG103522US$138.1k2026–202811 Sept 2026reporter.nih.gov
R03Health Trajectories During Transitions Into and Out of Caregiving in Later Life: The Role of Caregiving HistoryR03AG104414US$78.8k2026–20284 Sept 2026reporter.nih.gov
R01For Better or For Worse: Examining the Longitudinal Interplay Between Insomnia Symptoms and Cognitive Function in Older Couples-A Pathway to Understanding Alzheimer's Disease ProgressionR01AG099824US$540.4k2026–203019 Aug 2026reporter.nih.gov
UH3Developing a novel agonist of CD137 for cancer immunopreventionUH3CA290305US$837.7k2024–20293 Aug 2026reporter.nih.gov
R24Foundational Porcine Stem Cell and Genetic Tools to Enable Rigorous, Reproducible Generation of Large-Animal ModelsR24OD042576US$774k2026–203029 Jul 2026reporter.nih.gov
R00The role of impaired mitophagy and mitochondrial dysfunction in glaucomatous neurodegenerationR00EY032982US$250.7k2021–202714 Jul 2026reporter.nih.gov
National Institute of General Medical Sciences
R35Organelle transport and organization in mammalian oogenesisR35GM158131US$413k2025–20308 Jun 2026reporter.nih.gov
R21Beta3-adrenergic receptors and cardiovascular function in aging womenR21AG101519US$433.1k2026–202825 May 2026reporter.nih.gov
National Institute of Neurological Disorders and Stroke
R21Altered arterial smooth muscle in cerebrovascular dysfunction during aging: remodeling of adhesion moleculesR21NS137267US$195.6k2025–202725 May 2026reporter.nih.gov
National Institute of Child Health and Human Development
R03Progesterone signaling in oviductal ciliated cells and reproductive longevityR03HD121464US$153.7k2026–202812 May 2026reporter.nih.gov
National Institute of General Medical Sciences
R35Genome evolution across complex trait hierarchiesR35GM149238US$384.4k2023–20287 Apr 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Cardiomyocyte TRPV4 and Angiotensin-II induced ventricular arrhythmia with agingR01HL136292US$418.2k2017–202823 Mar 2026reporter.nih.gov
R01SGLT2 inhibition as a therapeutic strategy to reverse arterial stiffening in agingR01AG082413US$603.6k2024–202923 Mar 2026reporter.nih.gov
National Institute of Biomedical Imaging and Bioengineering
R01Multimodal, Porous, Starfish-Like Soft Wearable Bioelectronic Systems for Motion-Artifact-Resilient, Real-Time and High-Accuracy Cardiac MonitoringR01EB038287US$598k2026–203011 Mar 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Sex-specific myofilament dysfunction in postmenopausal HFpEFR01HL171047US$398.8k2023–202811 Feb 2026reporter.nih.gov
R01Investigating the role of the gut-brain axis in Alzheimer's Disease mitigation: 7T MRI, iNOS inhibition and inulin dietR01AG089493US$676.6k2026–203028 Jan 2026reporter.nih.gov
R21Targeting LARP6 in aging-associated heart failureR21AG095557US$429.4k2025–202712 Dec 2025reporter.nih.gov